Crimi, C. Et Al. 2023. High-flow nasal oxygen versus conventional oxygen therapy in patients with COVID-19 pneumonia and mild hypoxaemia: a randomised controlled trial. THORAX , no.4 , 354-361.

Crimi, C., Noto, A., Madotto, F., Ippolito, M., Nolasco, S., Campisi, R., ... De Vuono, S.(2023). High-flow nasal oxygen versus conventional oxygen therapy in patients with COVID-19 pneumonia and mild hypoxaemia: a randomised controlled trial. THORAX , no.4, 354-361.

Crimi, Claudia Et Al. "High-flow nasal oxygen versus conventional oxygen therapy in patients with COVID-19 pneumonia and mild hypoxaemia: a randomised controlled trial," THORAX , no.4, 354-361, 2023

Crimi, Claudia Et Al. "High-flow nasal oxygen versus conventional oxygen therapy in patients with COVID-19 pneumonia and mild hypoxaemia: a randomised controlled trial." THORAX , no.4, pp.354-361, 2023

Crimi, C. Et Al. (2023) . "High-flow nasal oxygen versus conventional oxygen therapy in patients with COVID-19 pneumonia and mild hypoxaemia: a randomised controlled trial." THORAX , no.4, pp.354-361.

@article{article, author={Claudia Crimi Et Al. }, title={High-flow nasal oxygen versus conventional oxygen therapy in patients with COVID-19 pneumonia and mild hypoxaemia: a randomised controlled trial}, journal={THORAX}, year=2023, pages={354-361} }